Efficacy and safety of elinzanetant, a selective neurokinin-1,3 receptor antagonist for vasomotor symptoms: a dose-finding clinical trial (SWITCH-1).
| Autor: | Simon, James A., Anderson, Richard A., Ballantyne, Elizabeth, Bolognese, James, Caetano, Cecilia, Joffe, Hadine, Kerr, Mary, Panay, Nick, Seitz, Christian, Seymore, Susan, Trower, Mike, Zuurman, Lineke, Pawsey, Steve |
|---|---|
| Zdroj: | Menopause (10723714); Mar2023, Vol. 30 Issue 3, p239-246, 8p |
| Databáze: | Complementary Index |
| Externí odkaz: |
|